Anglo-Swedish drugmaker AstraZeneca plans to invest $3.5 billion in the US to expand the company’s research and manufacturing footprint by the end of 2026.

BASF announced plans to invest in additional production capacity for its X3D technology, a new additive manufacturing technology for catalysts based on 3D printing. The...

Dutch specialty chemicals producer Nouryon has completed the capacity expansion for organic peroxides at its manufacturing facility in Ningbo, China. The expansion...

Lonza, a global contract development and manufacturing organization (CDMO) for the pharmaceutical, biotech, and nutraceutical markets, announced today that it will invest...

German specialty chemicals group Evonik broke ground on its plant expansion for specialty amines at its site Nanjing, China, on Nov. 8. Construction work is expected to...

SABIC recently announced the official launch of its new US$170 (€157.7) million ultem resin manufacturing facility in Singapore, marking the company’s first advanced...

Belgium-headquartered pharmaceutical contract development and manufacturing organization (CDMO) Ardena announced plans to expand its bioanalytical services in the...

Sterling Pharma Solutions, a global contract development and manufacturing organization (CDMO), today announced the second phase of an expansion strategy at its Deeside...